Navigation Links
ANX in Medical News

ADVENTRX Pharmaceuticals Announces Closing of Financing

... SAN DIEGO, July 6 /PRNewswire-FirstCall/ -- ADVENTRX Pharmaceuticals, Inc. (NYSE Amex: anx ) announced today that it has completed the previously announced sale of shares of its 5% Series B convertible preferred stock pursuant to a registere...

ADVENTRX Grants Exclusive Rights to ANX-514 in South Korea

...h 25 /PRNewswire-FirstCall/ -- ADVENTRX Pharmaceuticals, Inc. (NYSE Amex: anx ) announced today that it has granted Shin Poong Pharmaceutical Co., Ltd. (...ted Mr. Byung Hwa Kim, Chief Executive Officer of Shin Poong. About anx -514 (docetaxel emulsion) ANX-514 is a novel nano-emulsion formulation ...

ADVENTRX Pharmaceuticals to Report Third Quarter 2008 Results

... simultaneous webcast at http://www.adventrx.com SAN DIEGO, Oct. 30 /PRNewswire-FirstCall/ -- ADVENTRX Pharmaceuticals, Inc. (Amex: anx ) today announced that it will host a conference call with simultaneous webcast to discuss third quarter 2008 results on Thursday, November 6th, 2008 ...

ADVENTRX Pharmaceuticals Reports Second Quarter 2008 Financial Results and Business Update

... simultaneous webcast at http://www.adventrx.com SAN DIEGO, Aug. 11 /PRNewswire-FirstCall/ -- ADVENTRX Pharmaceuticals, Inc. (Amex: anx ), a biopharmaceutical company focused on in-licensing, developing and commercializing proprietary product candidates primarily for the treatment of c...

ADVENTRX Pharmaceuticals to Report First Quarter 2008 Results

...fic); simultaneous webcast at http://www.adventrx.com SAN DIEGO, May 5 /PRNewswire-FirstCall/ -- ADVENTRX Pharmaceuticals, Inc. (Amex: anx ) today announced that it will host a conference call with simultaneous webcast to discuss first quarter 2008 results on Monday, May 12th, 2008 at 1:3...

QED International Associates Announces Quarterly Rebalancing of HealthShares(TM) Indexes

...uker Corporation (Nasdaq: BRKR ) Halozyme Therapeutic (Nasdaq: HALO ) Emerging Cancer Index (HHJ) Drop Adventrx Pharmaceuticals, Inc. (Amex: anx ) Keryx Biopharmaceuticals, Inc. (Nasdaq: KERX ) Add Dyanvax Technologies (Nasdaq: DVAX ) Synta Pharmaceuticals Corp. (Nasdaq: SNTA ) Enab...

ADVENTRX Pharmaceuticals to Present at The 10th Annual BIO CEO & Investor Conference

... SAN DIEGO, Feb. 5 /PRNewswire-FirstCall/ -- ADVENTRX Pharmaceuticals, Inc. (Amex: anx ), a biopharmaceutical research and development company focused on commercializing proprietary product candidates for the treatment of cancer and infe...

ADVENTRX Pharmaceuticals to Present at the 2007 RBC Capital Markets Healthcare Conference

... SAN DIEGO, Dec. 10 /PRNewswire-FirstCall/ -- ADVENTRX Pharmaceuticals, Inc. (Amex: anx ), a biopharmaceutical research and development company focused on commercializing proprietary product candidates for the treatment of cancer and infe...

ADVENTRX Pharmaceuticals to Present at the 13th Annual BIO-Europe Partnering Conference

... SAN DIEGO, Nov. 5 /PRNewswire-FirstCall/ -- ADVENTRX Pharmaceuticals, Inc. (Amex: anx ), a biopharmaceutical research and development company focused on commercializing proprietary product candidates for the treatment of cancer and infe...

ADVENTRX Pharmaceuticals to Present at the 18th Annual CIBC Healthcare Conference

... SAN DIEGO, Oct. 31 /PRNewswire-FirstCall/ -- ADVENTRX Pharmaceuticals, Inc. (Amex: anx ), a biopharmaceutical research and development company focused on commercializing proprietary product candidates for the treatment of cancer and infe...

More>>

ANX in Medical Technology

ADVENTRX Announces Results From ANX-514 Bioequivalence Study

... Updates guidance regarding strategic transaction process SAN DIEGO, May 7 /PRNewswire-FirstCall/ -- ADVENTRX Pharmaceuticals, Inc. (NYSE Amex: anx ) today announced results from its bioequivalence study of ANX-514 (docetaxel emulsion). ANX-514 was determined to have comparable overall safety as ...

ADVENTRX Announces Preliminary Response Rate Data From Discontinued Phase 3 Trial of CoFactor(R)

... SAN DIEGO, July 1 /PRNewswire-FirstCall/ -- ADVENTRX Pharmaceuticals, Inc. (Amex: anx ) today announced preliminary response rate results from its discontinued Phase 3 clinical trial of ANX-510, or CoFactor, the Company's folate-based b...

ADVENTRX Announces CoFactor(R) Phase 2b Clinical Trial Overall Survival Results

... SAN DIEGO, June 16 /PRNewswire-FirstCall/ -- ADVENTRX Pharmaceuticals, Inc. (Amex: anx ) today provided an update with regard to overall survival from its Phase 2b clinical trial of CoFactor for the treatment of first-line metastatic col...

ADVENTRX Presents CoFactor Data at the 2008 Annual Meeting of the American Society of Clinical Oncology (ASCO)

... SAN DIEGO, June 3 /PRNewswire-FirstCall/ -- ADVENTRX Pharmaceuticals, Inc. (Amex: anx ) announced today that it presented objective response rate and available safety data from the Company's Phase 2 clinical study of ANX-510, or CoFacto...

ADVENTRX Announces ANX-530 Safety Data From Registrational Bioequivalence Clinical Study

...e American Society of Clinical Oncology SAN DIEGO, May 16 /PRNewswire-FirstCall/ -- ADVENTRX Pharmaceuticals, Inc. (Amex: anx ) announced today that, in a registrational bioequivalence clinical study, ANX-530 demonstrated a statistically significant reduction in general disor...

ANX-201 Demonstrates a Unique Resistance Profile in Preclinical Tests

...esents Results at Keystone Symposia HIV Pathogenesis Conference SAN DIEGO, March 31 /PRNewswire-FirstCall/ -- ADVENTRX Pharmaceuticals, Inc. (Amex: anx ) announced that it presented preclinical results for ANX-201, the Company's broad-spectrum antiviral product candidate at the Keystone Symposia HIV P...

ADVENTRX to Present CoFactor Phase 2 Breast Cancer Data at the 2008 Annual Meeting of the American Society of Clinical Oncology (ASCO)

... SAN DIEGO, March 12 /PRNewswire-FirstCall/ -- ADVENTRX Pharmaceuticals, Inc. (Amex: anx ) announced today that preliminary data from the Company's Phase 2 clinical study of ANX-510, CoFactor(R), for the treatment of advanced breast cancer...

ADVENTRX to Present ANX-201 Preclinical Data at Keystone Symposia HIV Pathogenesis Conference

... SAN DIEGO, Jan. 31 /PRNewswire-FirstCall/ -- ADVENTRX Pharmaceuticals, Inc. (Amex: anx ), announced today that data from preclinical studies of ANX-201, the Company's broad spectrum antiviral product candidate, has been accepted for pres...

ADVENTRX Announces Completion of Patient Enrollment in Phase 2 Clinical Trial of CoFactor(R) for the Treatment of Advanced Breast Cancer

... SAN DIEGO, Dec. 5 /PRNewswire-FirstCall/ -- ADVENTRX Pharmaceuticals, Inc. (Amex: anx ), a biopharmaceutical research and development company focused on commercializing proprietary product candidates for the treatment of cancer and infe...

ADVENTRX Meets Primary Endpoint in ANX-530 Marketing-Enabling Clinical Study

... SAN DIEGO, Nov. 16 /PRNewswire-FirstCall/ -- ADVENTRX Pharmaceuticals, Inc. (Amex: anx ) today announced positive results from its marketing-enabling clinical study of ANX-530 (vinorelbine emulsion). Pharmacokinetic equivalence, the prim...
ANX in Biological Technology

ADVENTRX to Hold Second Quarter Results and Business Update Conference Call on August 12

... SAN DIEGO, Aug. 5 /PRNewswire-FirstCall/ -- ADVENTRX Pharmaceuticals, Inc. (NYSE Amex: anx ) today announced that it will hold a conference call on Wednesday, August 12, 2009 at 1:30 p.m. Pacific (4:30 p.m. Eastern) to review financial resul...

ADVENTRX Pharmaceuticals Announces Financing

... SAN DIEGO, Aug. 5 /PRNewswire-FirstCall/ -- ADVENTRX Pharmaceuticals, Inc. (NYSE Amex: anx ) announced today that it has obtained a commitment to purchase shares of convertible preferred stock pursuant to a registered direct offering to a si...

ADVENTRX Pharmaceuticals Announces Plans for Remainder of 2009

...nal manufacturing activities for ANX-530 NDA re-started SAN DIEGO, June 29 /PRNewswire-FirstCall/ -- ADVENTRX Pharmaceuticals, Inc. (NYSE Amex: anx ) today announced its plans for the remainder of 2009. Following the financing that closed earlier this month, ADVENTRX has re-started the fina...

ADVENTRX Pharmaceuticals Announces Closing of Financing

... SAN DIEGO, June 15 /PRNewswire-FirstCall/ -- ADVENTRX Pharmaceuticals, Inc. (NYSE Amex: anx ) today announced that it has completed the previously announced sale of shares of convertible preferred stock pursuant to a registered direct offerin...

ADVENTRX Pharmaceuticals Announces Financing

... SAN DIEGO, June 8 /PRNewswire-FirstCall/ -- ADVENTRX Pharmaceuticals, Inc. (NYSE Amex: anx ) announced today that it has obtained a commitment to purchase shares of convertible preferred stock pursuant to a registered direct offering to a si...

ADVENTRX Pharmaceuticals, Inc. Reports Fourth Quarter and Full Year 2008 Financial Results

... SAN DIEGO, March 25 /PRNewswire-FirstCall/ -- ADVENTRX Pharmaceuticals, Inc. (NYSE Amex: anx ) today reported financial results for the fourth quarter and year ended December 31, 2008. "2008 was a transition year for ADVENTRX in which we ...

ADVENTRX Announces Further Cost-Cutting Measures

... SAN DIEGO, March 20 /PRNewswire-FirstCall/ -- ADVENTRX Pharmaceuticals, Inc. (NYSE Amex: anx ) announced today that, effective April 3, it will reduce its full-time workforce to five employees and will discontinue substantially all of its deve...

ADVENTRX Exploring Strategic Options

..., Dec. 15 /PRNewswire-FirstCall/ -- ADVENTRX Pharmaceuticals, Inc. (Amex: anx ), a biopharmaceutical company focused on in-licensing, developing and comm...velopment and commercialization of its lead product candidates, ANX-530 and anx 514; the risk that ADVENTRX's stockholders will not approve a transaction r...

ADVENTRX Pharmaceuticals Reports Third Quarter 2008 Financial Results and Business Update

...GO, Nov. 6 /PRNewswire-FirstCall/ -- ADVENTRX Pharmaceuticals, Inc. (Amex: anx ), a biopharmaceutical company focused on in-licensing, developing and comm...uding funding the continued development and commercialization of ANX-530 or anx 514; the risk that restructuring costs may be greater than anticipated and ...

ADVENTRX Pharmaceuticals to Present at the Rodman & Renshaw 10th Annual Global Healthcare Conference

... SAN DIEGO, Nov. 4 /PRNewswire-FirstCall/ -- ADVENTRX Pharmaceuticals, Inc. (Amex: anx ) today announced that Mark Erwin, Senior Vice President, Operations of ADVENTRX, is scheduled to present at the Rodman & Renshaw 10th Annual Global H...
Other Tags
(Date:8/20/2014)... No matter how “lonely” a person may ... set of friends to be always there for them. However, ... concept of making new friends during adulthood : not ... taking care of one’s family to a near-slavish devotion to ... new person just is not the same as it was ...
(Date:8/20/2014)... 2014 Blaine Labs®, the creators ... RevitaDERM® Psoriasis Treatment to ease the redness, ... This all-in-one product was created to treat, moisturize, ... is powered by coal tar and formulated to ... effective ingredient. , RevitaDERM® Psoriasis Treatment is ...
(Date:8/20/2014)... First Choice Emergency Room , ... the United States, named Richard Daniels, DO the Medical ... , “We are pleased to announce that Dr. ... second facility in Pflugerville,” said Dr. James M. Muzzarelli, ... , Dr. Daniels received his undergraduate degree from Brigham ...
(Date:8/20/2014)... August 20, 2014 What to Do ... Locked Out of the Market, **FDAnews Webinar**, Sept. 11, ... http://www.fdanews.com/DoNowforUDI , Hospitals and other buyers of devices ... ineffective product tracking systems. , Complying with the FDA’s ... demands to implement UDI as soon as possible. ...
(Date:8/19/2014)... As moms and dads prepare their children to go ... normal routine of dropping their little ones off at daycare ... encourages them to use the opportunity to implement a ... Yarker explains, “Kids have small tummies, short attention spans, and ... food handouts, use snack time as another daily opportunity to ...
Breaking Medicine News(10 mins):Health News:‘How to Make Friends as an Adult by Just Being Yourself: Becoming a “People Person” In Three Steps or Less’ Gives Tips for Making Friends During Adulthood - Vinamy 2Health News:RevitaDERM® Psoriasis Treatment Now Available At Over 7,600 CVS/pharmacies 2Health News:First Choice Emergency Room Announces Dr. Richard Daniels as Medical Director of the Pflugerville – FM 685 Facility 2Health News:FDAnews Announces — What to Do Now for UDI: Don’t Lose Your Customers by Getting Locked Out of the Market Webinar, Sept. 9, 2014 2Health News:FDAnews Announces — What to Do Now for UDI: Don’t Lose Your Customers by Getting Locked Out of the Market Webinar, Sept. 9, 2014 3Health News:FDAnews Announces — What to Do Now for UDI: Don’t Lose Your Customers by Getting Locked Out of the Market Webinar, Sept. 9, 2014 4Health News:Child Nutritionist Kristen Yarker Wants Parents to Rethink Kids’ Snacks This Fall 2Health News:Child Nutritionist Kristen Yarker Wants Parents to Rethink Kids’ Snacks This Fall 3
(Date:8/18/2014)... mass is made up of rangelands, which include grasslands ... alarming rate. Woody plants, such as trees and shrubs, ... loss of critical habitat and causing a drastic change ... specifically meat. , Researchers with Arizona State University,s ... this loss in both the United States and Argentina. ...
(Date:8/18/2014)... Denmark, and the University of Wisconsin-Madison, USA, have developed a ... both climate and land use change. This new metric was ... of combined rates of climate and land use for the ... have just been published in Nature Climate Change , ... biodiversity and ecosystem function due to the individual or combined ...
(Date:8/18/2014)... with the pygmy phenotype is probably a selective ... team of researchers, but all African pygmy phenotypes ... a more recent adaptation than previously thought., "I,m ... their very challenging environments," said George H. Perry, ... "Tropical rainforests are difficult for humans to live ...
Breaking Biology News(10 mins):Trees and shrubs invading critical grasslands, diminish cattle production 2Trees and shrubs invading critical grasslands, diminish cattle production 3The double threat of climate and land use change enhances risks to biodiversity 2Pygmy phenotype developed many times, adaptive to rainforest 2
Other Contents